Department of Diagnostic Imaging, Rhode Island Hospital, Providence, USA.
J Radiol Case Rep. 2021 Feb 28;15(2):7-24. doi: 10.3941/jrcr.v15i2.3911. eCollection 2021 Feb.
The evolving nature of newer surgical techniques and devices adds to the challenge of interpreting breast imaging in the post lumpectomy setting. The BioZorb surgical marker placed at lumpectomy sites for post-operative radiation targeting has its own distinct imaging appearance on each modality. Determining the expected follow-up imaging findings unique to this relatively new device is an ongoing endeavor with minimal literature on this topic. The following series of cases of post BioZorb breast surveillance are one of the first reported in the literature to provide examples of developing asymmetries and new or enlarging masses adjacent to the BioZorb site along with the final pathologic diagnosis for each case. Pathology findings range from fat necrosis and foreign body reaction to recurrent disease.
新的手术技术和设备的不断发展增加了在保乳手术后进行乳房成像解释的难度。在保乳手术后进行放射治疗定位时，BioZorb 外科标记物在每种成像方式上都有其独特的成像表现。确定这种相对较新的设备的预期随访成像特征是一项持续的努力，但关于这个主题的文献很少。以下一系列 BioZorb 乳房监测后的病例是文献中首次报道的病例之一，这些病例提供了与 BioZorb 部位相邻的新出现或增大的肿块以及每个病例的最终病理诊断的发展不对称的例子。病理结果从脂肪坏死和异物反应到复发性疾病不等。
